Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Many mechanisms have been proposed to explain why immune responses against human tumor antigens are generally ineffective. For example, tumor cells have been shown to develop active immune evasion mechanisms. Another possibility is that tumor antigens are unable to optimally stimulate tumor-specific...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Valmori, D, Fonteneau, J, Valitutti, S, Gervois, N, Dunbar, R, Liénard, D, Rimoldi, D, Cerundolo, V, Jotereau, F, Cerottini, J, Speiser, D, Romero, P
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1999

Παρόμοια τεκμήρια

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
ανά: Valmori, D, κ.ά.
Έκδοση: (1999)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
ανά: Valmori, D, κ.ά.
Έκδοση: (2000)

An antigen-targeted approach to adoptive transfer therapy of cancer.
ανά: Valmori, D, κ.ά.
Έκδοση: (1999)

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
ανά: Romero, P, κ.ά.
Έκδοση: (1998)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
ανά: Valmori, D, κ.ά.
Έκδοση: (1999)

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
ανά: Pittet, M, κ.ά.
Έκδοση: (1999)

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
ανά: Speiser, D, κ.ά.
Έκδοση: (1999)

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
ανά: Speiser, D, κ.ά.
Έκδοση: (1999)

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
ανά: Valmori, D, κ.ά.
Έκδοση: (2000)

Immune monitoring in cancer immunotherapy.
ανά: Romero, P, κ.ά.
Έκδοση: (2000)

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
ανά: Chen, J, κ.ά.
Έκδοση: (2000)

The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
ανά: Hudrisier, D, κ.ά.
Έκδοση: (1998)

Tumor cell recognition efficiency by T cells.
ανά: Daniel E Speiser, κ.ά.
Έκδοση: (2005-03-01)

Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.
ανά: Juliette Desfrançois, κ.ά.
Έκδοση: (2010-01-01)

Quantitating T cell cross-reactivity for unrelated peptide antigens.
ανά: Ishizuka, J, κ.ά.
Έκδοση: (2009)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
ανά: Douglas McNeel, κ.ά.
Έκδοση: (2023-11-01)

Antigen presentation. Naturally processed peptides.
ανά: Elliott, T, κ.ά.
Έκδοση: (1990)

The efficiency of antigen recognition by CTL is determined by the frequency of serial TCR engagement.
ανά: Hudrisier, D, κ.ά.
Έκδοση: (1998)

Antigenic reactivity of peptides derived from wheat gluten with sera from patients with coeliac disease.
ανά: Rawcliffe, P, κ.ά.
Έκδοση: (1985)

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
ανά: Youde, S, κ.ά.
Έκδοση: (2000)

Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
ανά: Kessler, B, κ.ά.
Έκδοση: (1997)

Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
ανά: Aleksic, M, κ.ά.
Έκδοση: (2010)

Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
ανά: Danila Valmori, κ.ά.
Έκδοση: (2004-11-01)

Reactivity of sulfonylbutadienes. Synthesis of Ginsenol analogues
ανά: David Diez, κ.ά.
Έκδοση: (2010-10-01)

A tumor-binding antibody with cross-reactivity to viral antigens
ανά: Michael J. Campa, κ.ά.
Έκδοση: (2025-02-01)

Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.
ανά: Griffiths, E, κ.ά.
Έκδοση: (1998)

High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence
ανά: Laura Carretero-Iglesia, κ.ά.
Έκδοση: (2020-01-01)

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.
ανά: Larsson, M, κ.ά.
Έκδοση: (2000)

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
ανά: André, P, κ.ά.
Έκδοση: (1998)

Synthesis and reactivity of novel gamma-phosphate modified ATP analogues.
ανά: Lee, SE, κ.ά.
Έκδοση: (2009)

Synthesis and reactivity of novel γ-phosphate modified ATP analogues
ανά: Lee, SE, κ.ά.
Έκδοση: (2009)

Synthesis of a novel analogue of peptide ProGlyPro
ανά: A. V. Baranov, κ.ά.
Έκδοση: (2006-12-01)

Identifying individual T cell receptors of optimal avidity for tumor antigens
ανά: Michaël eHebeisen, κ.ά.
Έκδοση: (2015-11-01)

IMMUNOMODULATORY ACTIVITY OF ANTIMICROBIAL PEPTIDE INDOLICIDIN AND ITS STRUCTURAL ANALOGUES
ανά: A. Yu. Artamonov, κ.ά.
Έκδοση: (2014-07-01)

363 Identification of dark antigen® reactive T cell receptors from tumor-infiltrating lymphocytes
ανά: Özcan Met, κ.ά.
Έκδοση: (2023-11-01)

Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
ανά: Kessler, B, κ.ά.
Έκδοση: (1998)

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
ανά: Lahman, MC, κ.ά.
Έκδοση: (2022)

Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors
ανά: Wenwen Wang, κ.ά.
Έκδοση: (2023-03-01)

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
ανά: Smith, D, κ.ά.
Έκδοση: (2002)

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
ανά: Speiser, D, κ.ά.
Έκδοση: (1997)